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The study describes a case of a 67-year-old female who developed a Stage I E marginal zone lymphoma of the right triceps muscle
1monthafterinﬂuenzavaccinationatthesamesite.Shewastreated withsinglemodality,involvedﬁeldradiationtherapy(IFRT)to
4000cGy in 20 fractions with excellent response and no evidence of disease after one year followup.
1.Introduction
Extranodal marginal zone lymphomas (ENMZLs) constitute
7-8% of all B-cell lymphomas [1]. They most commonly
occur in the stomach but can present in the salivary glands,
Waldeyer’s ring, large and small intestine, thyroid, eye (orbit
and conjunctiva), lung, breast, and skin [2]. Involvement of
the muscle is very rare and accounts for less than 1% of all
mucosa-associated lymphoid tissue (MALT) lymphomas [3].
There is some evidence to suggest that MALT lymphoma
develops as a result of prolonged antigenic stimulation by
autoantigens and/or microbial pathogens. For example,
MALT lymphoma of the thyroid gland develops in patients
with Hashimoto’s thyroiditis [4] and in salivary glands of
patients with Sj¨ ogren’s syndrome [5]. The most common
association is, however, Helicobacter pylori infection and
MALT lymphoma of the stomach [6].
The case presented herein is a rare case of a 67-year-old
female who developed MALT lymphoma of the right triceps
muscle after the inﬂuenza vaccination at the same site one
month earlier.
2.Case Report
A 67-year-old female received inﬂuenza vaccination in sum-
mer, 2009. One month later she developed pain and lump in
therightarmreportedlyinthesame areathatwasvaccinated.
Upon initial presentation her symptoms were presumed to
be secondary to a torn triceps muscle. She was thus referred
to an orthopedist who recommended imaging workup.
Magnetic resonance imaging (MRI) of the right upper arm
showed a 4.3 × 1.1 × 7.5cm enhancing mass in the posterior
lateral aspect of the long head of the right triceps muscle
(Figure 1).
Corebiopsyrevealedlowgradelymphoma ofsmall B-cell
type. Additional tissue sampling was recommended for fur-
ther classiﬁcation and immunophenotyping. She underwent
incisional biopsy that demonstrated B-cell-type lymphoma
inﬁltrating the skeletal muscle. Immunohistochemical stain-
ing was positive for CD 20, BCL2 and pax-5 and negative for
CD3, CD5, CD10, CD 23, BCL 6, and cyclin D1, consistent
with marginal zone lymphoma. Bone marrow biopsy was
negative. Lactate dehydrogenase (LDH) was within normal2 ISRN Hematology
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Figure 1: Pretreatment axial (a) and sagittal (b) postgadolinium
contrast MRI of the right upper arm with enhancing mass in the
posterior lateral aspect of the long head of the right triceps muscle
outlined in red.
limits. She was therefore staged I E with International Prog-
nostic Index (IPI) score of 1 by virtue of her age.
After multidisciplinary consultations, a course of deﬁni-
tiveradiation therapy was recommended. Sheunderwent CT
simulation in the supine position with alpha-cradle for im-
mobilization. The target lesion was contoured as the gross
tumor volume (GTV). The GTV was expanded by 2cm to
create the planned treatment volume (PTV).
She received 40Gy in 20 fractions with 6MV photons
utilizing 3D conformal radiation therapy. She tolerated the
treatment well without any unexpected side eﬀects.
Physical examination at 1 and 6 months and 1 year after
treatment revealed no palpable residual mass, swelling or
skin erythema, or range of motion deﬁcits.
6-month posttreatment MRI of the right upper arm
demonstratedexcellentresponsewithnoevidenceofresidual
disease (Figure 2). Computerized tomography of the chest,
abdomen and pelvis (CT CAP) at 1 year showed no evidence
of disease.
3.Discussion
ExtranodalMALTlymphomacomprises7-8%ofnon-Hodg-
kin lymphoma (NHL) and most commonly involves the
stomach. [1] As such, the treatment of stomach MALT with
involved ﬁeld radiation therapy has been well established,
yielding excellent outcomes with over 90% local control in
most series [7–9].
Nongastric marginal zone lymphoma is less common,
and treatment of this entity is much less deﬁned in the liter-
ature. In a large International Extranodal Lymphoma Study
Group (IELSG)series of180 patientswith Nongastric MALT,
a variety of treatment approaches were employed, including
chemotherapy, surgery orradiation alone,orin combination
[3].
Even rarer is Nongastric marginal zone lymphoma in the
skeletal muscle, so much so that the large Nongastric MALT
series, published by the IELSG, did not include any patients
with marginal zone lymphoma of the skeletal muscle [3].
To our knowledge, only two cases of ENMZL of the skeletal
(a) (b)
Figure 2: Posttreatment axial (a) and sagittal (b) postgadolinium
contrastMRI ofthe rightupper armdemonstratingresolutionafter
ac o u r s eo fI F R Tt o4 0G y .
muscle have been reported [10, 11]. Gill et al. [10]r e p o r t e d
a case of stage IV marginal zone lymphoma of the right
forearm in the distal biceps and proximal triceps muscles
with pulmonary metastases that was treated initially with
6 cycles of standard dose cyclophosphamide, doxorubicin,
oncovin and prednisone (CHOP), radiation therapy for
locally recurrent disease 4 years later, and ﬁnally chemother-
apy for a second recurrence. That case may lend support to
the claim that primary skeletal lymphoma tends to be more
aggressive, present late stage, and portend a poor prognosis
[10, 12]. However, our patient presented with early stage (I
E) primary skeletal muscle marginal zone lymphoma and an
IPI score of 1.
It was quite interesting that our patient developed MALT
in the right triceps muscle a few weeks after receiving in-
ﬂuenza vaccination at the same site. There is mounting evi-
dence supporting the association between antigenic stimu-
lation and/or microbial pathogens and MALT lymphoma.
For example, patients with autoimmune diseases such as
Sj¨ ogren’s and Hashimoto’s thyroiditis have an increased risk
of MALT of the salivary glands and thyroid, respectively
[4, 5]. There is also a strong association between H. pylori
infection and stomach MALT, and yet to be conﬁrmed
associations between Chlamydia psittaci and adnexal MALT
lymphoma and hepatitis C virus (HCV) infection with
MALT, splenic, and nodal MZL [13, 14]. Whether our
patient’s triceps MALT was coincidental or related to her in-
ﬂuenza vaccination remains undetermined. Nonetheless, she
responded well to IFRT alone with no radiological evidence
of residual, recurrent, or distant disease.
4.Conclusion
The relationship between inﬂuenza vaccine injection and the
development of MALT lymphoma in this patient is specula-
tive but is, undeniably, an interesting conﬂuence of events.
Although the available literature suggests that primary skele-
tal muscle NHL is associated with poor prognosis, the caseISRN Hematology 3
presented here suggests that IFRT alone can be an eﬀective
treatment for early stage primary skeletal marginal zone
lymphoma.
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